Johnson David Michael's Form 4 filing
Aura Biosciences, Inc.AURA · filed Nov 9, 2023
- Accession no.
- 0000950170-23-062214
- Filed
- Nov 9, 2023
- Trade date
- Nov 7-8, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market purchases total $1.43M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Johnson David MichaelCIK 0001808098 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | Common Stock | PPurchaseAcquired | +76,000 | $7.17F1 | +$544,920 | 126,066 | Direct | |
| Nov 7, 2023 | Common Stock | PPurchaseAcquired | +47,000 | $7.17F1 | +$336,990 | 65,000 | Indirect | |
| Nov 7, 2023 | Common Stock | PPurchaseAcquired | +47,000 | $7.17F1 | +$336,990 | 65,000 | Indirect | |
| Nov 8, 2023 | Common Stock | PPurchaseAcquired | +9,601 | $7.30F4 | +$70,087.3 | 135,667 | Direct | |
| Nov 8, 2023 | Common Stock | PPurchaseAcquired | +10,000 | $7.30F4 | +$73,000 | 75,000 | Indirect | |
| Nov 8, 2023 | Common Stock | PPurchaseAcquired | +10,000 | $7.30F4 | +$73,000 | 75,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $6.50 to $7.42, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 3 transactions in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $7.22 to $7.42, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 3 transactions in Table I.